PEREGRINE CAPITAL MANAGEMENT LLC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,733,186
-6.3%
126,393
-15.3%
0.17%
+2.4%
Q2 2023$6,121,594
+14.8%
149,198
-0.0%
0.17%
+8.4%
Q1 2023$5,334,088
+107117.8%
149,247
+13.3%
0.15%
-1.3%
Q4 2022$4,975
-99.9%
131,711
+6.7%
0.16%
-11.9%
Q3 2022$5,458,000
+13.2%
123,396
-5.2%
0.18%
+22.1%
Q2 2022$4,821,000
-0.1%
130,224
-0.1%
0.14%
+27.2%
Q1 2022$4,827,000
+13.5%
130,320
-6.7%
0.11%
+34.1%
Q4 2021$4,252,000
-6.6%
139,721
+2.9%
0.08%
-9.6%
Q3 2021$4,554,000
-29.8%
135,787
-16.5%
0.09%
-19.0%
Q2 2021$6,483,000
-16.3%
162,528
-5.7%
0.12%
-19.4%
Q1 2021$7,749,000
-23.1%
172,348
-3.3%
0.14%
-25.0%
Q4 2020$10,081,000
+19.8%
178,304
+0.6%
0.19%
-13.9%
Q3 2020$8,412,000
-26.5%
177,284
-8.6%
0.22%
-31.4%
Q2 2020$11,440,000
+8.8%
194,030
-12.7%
0.32%
-13.8%
Q1 2020$10,512,000
-17.5%
222,342
+5.5%
0.38%
+16.4%
Q4 2019$12,737,000
+9.4%
210,843
+8.5%
0.32%
+2.2%
Q3 2019$11,642,000
-3.4%
194,329
+3.6%
0.32%
+6.4%
Q2 2019$12,055,000
-21.5%
187,561
-0.8%
0.30%
-22.4%
Q1 2019$15,348,000
+6.1%
189,088
-29.3%
0.38%
-5.9%
Q4 2018$14,461,000
+4.1%
267,492
-0.7%
0.41%
+24.0%
Q3 2018$13,895,000
+2.0%
269,382
-17.6%
0.33%
-3.2%
Q2 2018$13,616,000326,7650.34%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,136$133,7497.12%
Bellevue Group AG 9,743,900$368,027,1034.88%
M28 Capital Management LP 126,300$4,770,3514.55%
Sicart Associates LLC 246,258$9,301,1653.28%
Camber Capital Management LP 1,925,000$72,7072.49%
Privium Fund Management B.V. 148,807$5,557,9412.11%
Deep Track Capital, LP 1,205,773$45,542,0461.91%
BVF INC/IL 1,121,809$42,370,7261.79%
Orbimed Advisors 1,993,600$75,298,2721.44%
Parkman Healthcare Partners LLC 141,115$5,329,9141.42%
View complete list of IONIS PHARMACEUTICALS INC shareholders